Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNF32-DT is a long intergenic non-coding RNA transcribed from the region diverging from the RNF32 gene on chromosome 7. It is not translated into protein and is classified as a lincRNA based on genomic location and biotype. Such lincRNAs often play regulatory roles, particularly as *cis*-regulators that can modulate the expression of adjacent protein-coding genes (such as RNF32 itself). The specific function, expression pattern, and relevance to disease of RNF32-DT itself have not been well characterized in public databases, and there are no known disease associations or therapeutic targeting efforts for this transcript at present. Its study is representative of the broader category of lincRNAs whose detailed biological significance and clinical potential are the subject of continued investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1006 (RNF32-DT).